Advances in germline genetics for prostate cancer funded by the Prostate Cancer Foundation.

Advances in germline genetics for prostate cancer funded by the Prostate Cancer Foundation. Can J Urol. 2019 Oct;26(5S2):9 Authors: Soule HR, Miyahira AK Abstract The Prostate Cancer Foundation (PCF) is the world's largest non-profit organization that funds patient-centric prostate cancer research. PCF has funded numerous critical studies surrounding the identification, biology, and clinical significance of prostate cancer germline and somatic genetic alterations, and is accelerating the application of these findings to improving outcomes for patients and their families. PMID: 31629415 [PubMed - in process]
Source: Canadian Journal of Urology - Category: Urology & Nephrology Tags: Can J Urol Source Type: research